CHNALoncar China BioPharma ETF
CHNA Fund Description
CHNA tracks a tier-weighted index of companies directly involved in the growth of China’s pharmaceutical and biotech industry.
CHNA Factset Analytics Insight
CHNA targets China’s pharmaceutical and biotech (biopharma) sector. The fund includes pharmaceutical companies, biotech companies, drug manufacturers, diagnostics companies, wholesalers or distributors of biopharma products, and biopharma service providers. It is worth noting that manufacturers of pharmaceutical ingredients are excluded, as the fund focuses on innovation in the sector. CHNA uses a tiered weighting system. Starting from equal weight, all qualified constituents are assigned a weight adjustment based on market cap. Large cap stocks get a 140% adjustment, midcaps 100%, and small-caps 70%. The index is reconstituted on every second Monday of each February and August.
CHNA MSCI FaCS and Factor Box
MSCI FaCS is a standard method for evaluating and reporting the Factor characteristics of equity portfolios including ETFs. The Factor Box includes 6 Factors that MSCI has identified that historically provided a return premium. On the vertical axis, the Factor Groups, are displayed and the horizontal axis displays the Factor exposure, overweight, underweight or neutral.
CHNA Summary Data
CHNA Portfolio Data
CHNA Index Data
CHNA Portfolio Management
CHNA Tax Exposures
CHNA Fund Structure
CHNA Factset Analytics Block Liquidity
This measurement shows how easy it is to trade a $1 million USD block of CHNA. CHNA is rated a 3 out of 5.
CHNA Top 10 Holdings[View All]
CHNA Economic Development
CHNA Performance Statistics
CHNA Benchmark Comparison Summary
CHNA Benchmark Comparison Market Cap Size